{
    "2021-02-07": [
        [
            {
                "time": "",
                "original_text": "一级市场供应小幅回落 二级市场高收益延续跌势",
                "features": {
                    "keywords": [
                        "一级市场",
                        "二级市场",
                        "高收益",
                        "跌势"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020业绩前瞻：2020板块分化明显 下半年医疗服务等有序复苏",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩",
                        "板块分化",
                        "医疗服务",
                        "复苏"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-07",
                "original_text": "债券重大事件2021年2月7日星期日",
                "features": {
                    "keywords": [
                        "债券",
                        "重大事件"
                    ],
                    "sentiment_score": 0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "债券市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-07",
                "original_text": "海外信用评级汇总2021年2月7日星期日",
                "features": {
                    "keywords": [
                        "海外",
                        "信用评级"
                    ],
                    "sentiment_score": 0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "国际市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "美年健康信用评级再遭穆迪下调至B2 评级展望负面 主体评级下调",
                "features": {
                    "keywords": [
                        "美年健康",
                        "穆迪",
                        "信用评级",
                        "下调",
                        "负面"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "健康产业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：新冠变异后是否需要常态化免疫加强？智飞新高后继续强烈看好",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠变异",
                        "免疫加强",
                        "智飞",
                        "看好"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "穆迪：将美年健康企业家族评级由“B1”下调至“B2”，评级展望负面 评级展望下调为负面",
                "features": {
                    "keywords": [
                        "穆迪",
                        "美年健康",
                        "企业家族评级",
                        "下调",
                        "负面"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "健康产业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}